TNFRSF9(4-1BB) Reporter Jurkat Cell line
1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
4-1BB, also known as CD137 or TNFRSF9, is an inducible costimulatory receptor belonging to the tumor necrosis factor receptor superfamily. It is expressed in T cells, natural killer (NK) cells, and innate immune cells. Interaction between 4-1BB and its ligand (4-1BBL) promotes cell proliferation, survival, and cytokine production. Currently, drug development targeting 4-1BB is primarily for treating inflammation, autoimmune diseases, and cancer. Agonistic antibodies targeting 4-1BB have shown promising results in treating inflammation and autoimmune diseases. Combining therapies targeting 4-1BB with immune checkpoints or costimulatory targets will enhance anti-tumor effects.TNFRSF9 (4-1BB) Reporter Jurkat cell line is a luciferase reporter gene cell line constructed based on 4-1BBL/4-1BB. These cells stably express the 4-1BB gene and the luciferase reporter gene, which can be used to evaluate the in vitro activation effects of therapeutic antibodies targeting 4-1BB.The TNFRSF9 (4-1BB) Reporter Jurkat Cell Line can be used in combination with the FCGR2B CHO-K1 Cell Line to assess the interaction between antibodies and the FcγRIIb receptor when crosslinked, evaluating the in vitro activation effects of antibodies.
Species | Human |
Cat.No | ABC-RC091F |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Transfected Stable Cell Lines |
Size/Quantity | 1 vial |
Cell Type | T Lymphoblast |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Blood |
Disease | Acute T Cell Leukemia |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Reporter Stable Cell Lines |
Host Cell | Jurkat |
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
For research use only